These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24007718)

  • 1. Modification of the surfaces of medical devices to prevent microbial adhesion and biofilm formation.
    Desrousseaux C; Sautou V; Descamps S; Traoré O
    J Hosp Infect; 2013 Oct; 85(2):87-93. PubMed ID: 24007718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and control of biofilm-based medical-device-related infections.
    Francolini I; Donelli G
    FEMS Immunol Med Microbiol; 2010 Aug; 59(3):227-38. PubMed ID: 20412300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of bacterial adhesion on medical devices.
    Rodrigues LR
    Adv Exp Med Biol; 2011; 715():351-67. PubMed ID: 21557075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver.
    Monteiro DR; Gorup LF; Takamiya AS; Ruvollo-Filho AC; de Camargo ER; Barbosa DB
    Int J Antimicrob Agents; 2009 Aug; 34(2):103-10. PubMed ID: 19339161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient surface modification of biomaterial to prevent biofilm formation and the attachment of microorganisms.
    Bazaka K; Jacob MV; Crawford RJ; Ivanova EP
    Appl Microbiol Biotechnol; 2012 Jul; 95(2):299-311. PubMed ID: 22618687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging rules for effective antimicrobial coatings.
    Salwiczek M; Qu Y; Gardiner J; Strugnell RA; Lithgow T; McLean KM; Thissen H
    Trends Biotechnol; 2014 Feb; 32(2):82-90. PubMed ID: 24176168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured selenium for preventing biofilm formation on polycarbonate medical devices.
    Wang Q; Webster TJ
    J Biomed Mater Res A; 2012 Dec; 100(12):3205-10. PubMed ID: 22707390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections.
    Tamilvanan S; Venkateshan N; Ludwig A
    J Control Release; 2008 May; 128(1):2-22. PubMed ID: 18342974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface-attached cells, biofilms and biocide susceptibility: implications for hospital cleaning and disinfection.
    Otter JA; Vickery K; Walker JT; deLancey Pulcini E; Stoodley P; Goldenberg SD; Salkeld JA; Chewins J; Yezli S; Edgeworth JD
    J Hosp Infect; 2015 Jan; 89(1):16-27. PubMed ID: 25447198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control.
    Percival SL; Suleman L; Vuotto C; Donelli G
    J Med Microbiol; 2015 Apr; 64(Pt 4):323-334. PubMed ID: 25670813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocide resistance of Candida and Escherichia coli biofilms is associated with higher antioxidative capacities.
    Leung CY; Chan YC; Samaranayake LP; Seneviratne CJ
    J Hosp Infect; 2012 Jun; 81(2):79-86. PubMed ID: 22595316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifouling polyurethanes to fight device-related staphylococcal infections: synthesis, characterization, and antibiofilm efficacy.
    Francolini I; Donelli G; Vuotto C; Baroncini FA; Stoodley P; Taresco V; Martinelli A; D'Ilario L; Piozzi A
    Pathog Dis; 2014 Apr; 70(3):401-7. PubMed ID: 24532590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial adherence and biofilm formation on medical implants: a review.
    Veerachamy S; Yarlagadda T; Manivasagam G; Yarlagadda PK
    Proc Inst Mech Eng H; 2014 Oct; 228(10):1083-99. PubMed ID: 25406229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofilm formation on dental restorative and implant materials.
    Busscher HJ; Rinastiti M; Siswomihardjo W; van der Mei HC
    J Dent Res; 2010 Jul; 89(7):657-65. PubMed ID: 20448246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?
    Gilbert P; Allison DG; McBain AJ
    J Appl Microbiol; 2002; 92 Suppl():98S-110S. PubMed ID: 12000619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained prevention of biofilm formation on a novel silicone matrix suitable for medical devices.
    Steffensen SL; Vestergaard MH; Groenning M; Alm M; Franzyk H; Nielsen HM
    Eur J Pharm Biopharm; 2015 Aug; 94():305-11. PubMed ID: 26028273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofilms: recent developments on an old battle.
    de Carvalho CC
    Recent Pat Biotechnol; 2007; 1(1):49-57. PubMed ID: 19075832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of biofilm cell removal and killing and biocide efficacy using the microtiter plate test.
    Shakeri S; Kermanshahi RK; Moghaddam MM; Emtiazi G
    Biofouling; 2007; 23(1-2):79-86. PubMed ID: 17453732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escherichia coli serotype O157:H7 retention on solid surfaces and peroxide resistance is enhanced by dual-strain biofilm formation.
    Uhlich GA; Rogers DP; Mosier DA
    Foodborne Pathog Dis; 2010 Aug; 7(8):935-43. PubMed ID: 20367070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation of Campylobacter jejuni to biocides used in the food industry affects biofilm structure, adhesion strength, and cross-resistance to clinical antimicrobial compounds.
    Techaruvichit P; Takahashi H; Kuda T; Miya S; Keeratipibul S; Kimura B
    Biofouling; 2016 Aug; 32(7):827-39. PubMed ID: 27353218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.